Skip to main content

Table 4 Efficacy and safety outcomes of LAA subgroup

From: Influence of tirofiban on stroke outcome after mechanical thrombectomy in acute vertebrobasilar artery occlusion

Outcomes

Tirofiban

n = 47

Without Tiofiban

n = 35

p Value

 

Mode l

  

Mode 2

 

OR

95% CI

Adjusted

p Value

OR

95% CI

Adjusted

p Value

In-hospital death

7 (14.9)

11 (31.4)

0.074

0.691

0.197–2.425

0.564 b

0.691

0.197–2.425

0.564 e

Death at 3 monthsa

12 (26.1)

16 (45.7)

0.066

0.779

0.192–3.164

0.727 c

0.989

0.254–3.855

0.988 f

mRS 0–2, 3 monthsa

21 (45.7)

14 (40.0)

0.611

0.836

0.268–2.613

0.759 d

0.964

0.328–2.836

0.947 g

  1. LAA large artery atherosclerosis, OR odds ratio, CI confidence interval, mRS modified Rankin Scale
  2. a1 patient were lost to follow-up
  3. bAdjusted for age, PT/INR, TICI ≥ 2b
  4. cAdjusted for age, coronary artery disease, previous TIA/stroke, creatinine, TICI ≥ 2b
  5. dAdjusted for age, previous TIA/stroke, creatinine, TICI ≥ 2b
  6. eAdjusted for age, PT/INR, TICI ≥ 2b
  7. fAdjusted for age, previous TIA/stroke, PT/INR
  8. gAdjusted for age, previous TIA/stroke